Cyclacel Pharma (CYCC) Tops Q3 EPS by 18c
Cyclacel Pharma (NASDAQ: CYCC) reported Q3 EPS of ($0.47), $0.18 better than the analyst estimate of ($0.65).
For earnings history and earnings-related data on Cyclacel Pharma (CYCC) click here.
Cyclacel Pharma (NASDAQ: CYCC) reported Q3 EPS of ($0.47), $0.18 better than the analyst estimate of ($0.65).
For earnings history and earnings-related data on Cyclacel Pharma (CYCC) click here.